R&D Systems™ Recombinant Human PD-L2/B7-DC Fc Chimera Protein, CF
Extensive quality control produces lot-to-lot consistency that instills confidence in results and ensures reproducibility. Applications: Binding Activity
Manufacturer: R&D Systems™ 1224PL100
DescriptionMeasured by its binding ability in a functional ELISA. Immobilized recombinant human (rh) PD-L2 at 1 μg/mL (100 μL/well) can bind rhPD-1 with a linear range of 7.5-500 ng/mL.
|Lyophilized from a 0.2 µm filtered solution in PBS.|
|M.W. (Observed): 70-80 kDa, reducing conditions; M.W. (theoretical): 49 kDa (monomer)|
|>90%, by SDS-PAGE under reducing conditions and visualized by silver stain.|
|Mouse myeloma cell line, NS0-derived human PD-L2/B7-DC protein Human PD-L2 (Leu20-Pro219) (N-terminus) Accession # Q9BQ51 IEGRMD Human IgG1 (Pro100-Lys330) (C-terminus)|
|PD-L2/B7-DC Fc Chimera|
|Use a manual defrost freezer and avoid repeated freeze-thaw cycles. 12 months from date of receipt, -20°C to -70°C as supplied. 1 month, 2°C to 8°C under sterile conditions after reconstitution. 3 months, -20°C to -70°C under sterile conditions after reconstitution.|
|<1.0 EU / 1 µg of the protein by the LAL method.|
|Reconstitute at 100 µg/mL in sterile PBS.|
We continue to work to improve your shopping experience and your feedback regarding this content is very important to us. Please use the form below to provide feedback related to the content on this product.